Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala

Alcohol

Volumn 45, Issue 7, 2011, Pages 621-630

  Lam, Minh P ^a   Gianoulakis, Christina ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Addiction; Central amygdala; Corticotropin releasing hormone; Dynorphin; Ethanol; Microdialysis

Indexed keywords

ALCOHOL; ANTALARMIN; ANTISAUVAGINE 30; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DYNORPHIN[1-8];

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CENTRAL NUCLEUS (AMYGDALA); IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PROTEIN SECRETION; RADIOIMMUNOASSAY; RAT;

AMPHIBIAN PROTEINS; AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DYNORPHINS; ETHANOL; MALE; MICRODIALYSIS; MICROINJECTIONS; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; PYRIMIDINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

RATTUS;

EID: 81155161950     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2011.05.001     Document Type: Article

References (53)

1. Amaral D., Insausti R. Retrograde transport of D-[3H]-aspartate injected into the monkey amygdaloid complex. Exp. Brain Res. 1992, 88:375-388.
2. Bajo M., Cruz M.T., Siggins G.R., Messing R., Roberto M. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8410-8415.
3. Bals-Kubik R., Herz A., Shippenberg T.S. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology (Berl) 1989, 98:203-206.
4. Barson J.R., Carr A.J., Soun J.E., Sobhani N.C., Rada P., Leibowitz S.F., et al. Opioids in the hypothalamic paraventricular nucleus stimulate ethanol intake. Alcohol. Clin. Exp. Res. 2010, 34:214-222.
5. Bert L., Favale D., Jego G., Greve P., Guilloux J.P., Guiard B.P., et al. Rapid and precise method to locate microdialysis probe implantation in the rodent brain. J. Neurosci. Methods 2004, 140:53-57.
6. Carlezon W.A.J., Miczek K.A. Ascent of the kappa-opioid receptor in psychopharmacology. Psychopharmacology (Berl) 2010, 210:107-108.
7. Charmandari E., Constantine T., Chrousos G. Endocrinology of the stress response. Annu. Rev. Physiol. 2005, 67:259-284.
8. Chu K., Koob G.F., Cole M., Zorrilla E.P., Roberts A.J. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol. Biochem. Behav. 2007, 86:813-821.
9. Ciccocioppo R., Gehlert D.R., Ryabinin A., Kaur S., Cippitelli A., Thorsell A., et al. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond. Alcohol 2009, 43:491-498.
10. Cruz M.T., Bajo M.B., Maragnoli E.M., Tabakoff B., Siggins G.R., Roberto M. Type 7 adenylyl cyclase is involved in the ethanol and CRF sensitivity of GABAergic synapses in mouse central amygdala. Front. Neurosci. 2011, 4:207.
11. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995, 20:789-819.
12. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:5274-5278.
13. Funk C.K., Koob G.F. A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res. 2007, 1155:172-178.
14. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotrophin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 2006, 26:11324-11332.
15. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 2007, 61:78-86.
16. Funk D., Li Z., Lê A.D. Stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 2006, 138:235-243.
17. Fu Y., Pollandt S., Liu J., Krishnan B., Genzer K., Orozco-Cabal L., et al. Long-term potentiation (LTP) in the central amygdala (CeA) is enhanced after prolonged withdrawal from chronic cocaine and requires CRF1 receptors. J. Neurophysiol. 2007, 97:937-941.
18. Jarjour S.J., Bai L., Gianoulakis C. Effect of acute ethanol administration on the release of opioid peptides from the midbrain including the ventral tegmental area. Alcohol. Clin. Exp. Res. 2009, 33:1033-1043.
19. Kandel E.R., Schwartz J.H. Molecular biology of learning: modulation of transmitter release. Science 1982, 218:433-443.
20. Kendrick K.M. Microdialysis measurement of in vivo neuropeptide release. J. Neurosci. Methods 1990, 34:35-46.
21. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56:18-31.
22. Kovacs K.M., Szakall I., O'Brien D., Wang R., Vinod K.Y., Saito M., et al. Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol. Clin. Exp. Res. 2005, 29:730-738.
23. Läck A.K., Floyd D.W., McCool B.A. Chronic ethanol ingestion modulates proanxiety factors expressed in rat central amygdala. Alcohol 2006, 36:83-90.
24. Lam M.P., Marinelli P.W., Bai L., Gianoulakis C. Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. Psychopharmacology (Berl) 2008, 201:261-271.
25. Lam M.P., Gianoulakis C. Effects of acute ethanol on corticotropin-releasing hormone and β-endorphin systems at the level of the rat central amygdala. Psychopharmacology (Berl) 2011, In press.
26. Land B.B., Bruchas M.R., Lemos J.C., Xu M., Melief E.J., Chavkin C. The dysphoric component of stress is encoded by activation of the dynorphin k-opioid system. J. Neurosci. 2008, 28:407-414.
27. Lê A.D., Harding S., Juzytsch W., Watchus J., Shalev U., Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 2000, 150:317-324.
28. Lindholm S., Ploj K., Franck J., Nylander I. Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol 2000, 22:165-171.
29. Lindholm S., Werme M., Brené S., Franck J. The selective k-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Behav. Brain Res. 2001, 120:137-146.
30. Liu J., Yu B., Neugebauer V., Grigoriadis D.E., Rivier J., Vale W.W., et al. Corticotropin-releasing factor and Urocortin I modulate excitatory glutamatergic synaptic transmission. J. Neurosci. 2004, 24:4020-4029.
31. Liu X., Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 2002, 22:7856-7861.
32. Lowery E.G., Sparrow A.M., Breese G.R., Knapp D.J., Thiele T.E. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol. Clin. Exp. Res. 2008, 32:240-248.
33. Marchant N.J., Densmore V.S., Osborne P.B. Coexpression of prodynorphin and corticotropin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J. Comp. Neurol. 2007, 504:702-715.
34. Marinelli P.W., Lam M., Bai L., Quirion R., Gianoulakis C. A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol. Clin. Exp. Res. 2006, 30:982-990.
35. Nie Z., Schweitzer P., Roberts A.J., Madamba S.G., Moore S.D., Siggins G.R. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 2004, 303:1512-1514.
36. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1996, Academic, New York.
37. Perreault M.L., Graham D., Bisnaire L., Simms J., Hayton S., Szechtman H. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms. Neuropsychopharmacology 2006, 31:1967-1981.
38. Perreault M.L., Graham D., Scattolon S., Wang Y., Szechtman H., Foster J.A. Cotreatment with kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Psychopharmacology (Berl) 2007, 194:485-496.
39. Przewlocka B., Turchan J., Lasoń W., Przewlocki R. Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci. Lett. 1997, 238:13-16.
40. Quirion R., Weiss A.S., Pert C.B. Comparative pharmacological properties and autoradiographic distribution of [3H]ethylketocyclazocine binding sites in rat and guinea pig brain. Life Sci. 1983, 33:183-186.
41. Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., et al. Corticotropin releasing factor-induced amydala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol. Psychiatry 2010, 67:831-839.
42. Roberto M., Madamba S.G., Moore S.D., Tallent M.K., Siggins G.R. Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:2053-2058.
43. Royer S., Martina M., Paré D. An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J. Neurosci. 1999, 19:10575-10583.
44. Ryabinin A.E., Bachtell R.K., Heinrichs S.C., Lee S., Rivier C., Olive M.F., et al. The corticotrophin-releasing factor/Urocortin system and alcohol. Alcohol. Clin. Exp. Res. 2002, 26:714-722.
45. Sabino V., Cottone P., Koob G.F., Steardo L., Lee M.J., Rice K.C., et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 2006, 189:175-186.
46. Shippenberg T.S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 1993, 265:53-59.
47. Sillaber I., Rammes G., Zimmerman S., Mahal B., Zieglgänsberger W., Wurst W., et al. Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science 2002, 296:931-933.
48. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:2046-2050.
49. Sperling R.E., Gomes S.M., Sypek E.I., Carey A.N., McLaughlin J.P. Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration. Psychopharmacology (Berl) 2010, 210:199-209.
50. Walker B.M., Koob G.F. Pharmacological evidence for a motivational role of k-opioid systems in ethanol dependence. Neuropsychopharmacology 2008, 33:643-652.
51. Walker B.M., Zorrilla E.P., Koob G.F. Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict. Biol. 2010, 16:116-119.
52. Wee S., Koob G.F. The role of the dynorphin-k opioid system in the reinforcing effects of drugs of abuse. Psychopharmacology (Berl) 2010, 210:121-135.
53. Yakovleva T., Bazov I., Cebers G., Marinova Z., Hara Y., Ahmed A., et al. Prodynorphin storage and processing in axon terminals and dendrites. FASEB J 2006, 20:2124-2126.